AR001840A1 - Compositions and methods for detecting and treating acquired immunodeficiency syndrome - Google Patents

Compositions and methods for detecting and treating acquired immunodeficiency syndrome

Info

Publication number
AR001840A1
AR001840A1 AR33638296A AR33638296A AR001840A1 AR 001840 A1 AR001840 A1 AR 001840A1 AR 33638296 A AR33638296 A AR 33638296A AR 33638296 A AR33638296 A AR 33638296A AR 001840 A1 AR001840 A1 AR 001840A1
Authority
AR
Argentina
Prior art keywords
compositions
methods
acquired immunodeficiency
detecting
immunodeficiency syndrome
Prior art date
Application number
AR33638296A
Other languages
Spanish (es)
Original Assignee
Tomson U S A Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tomson U S A Ltd filed Critical Tomson U S A Ltd
Publication of AR001840A1 publication Critical patent/AR001840A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)

Abstract

La presente invención se refiere al área de inmunología y virología, y especialmente a composiciones obtenibles a partir de células de timo demamíferos que son útiles como agentes de diagnóstico, vacunas, y agentes terapéuticos del virusde inmunodeficiencia humana (HIV) y enfermedadesrelacionadas tales como síndrome de inmonudeficiencia adquirida (SIDA) y complejo relacionado con SIDA (ARC). También se describen los métodos dediagnósticos, la vacunación, y los métodosterapéu ticos, así como equipos que emplean estas composiciones.The present invention relates to the area of immunology and virology, and especially to compositions obtainable from demammal thymus cells that are useful as diagnostic agents, vaccines, and therapeutic agents of human immunodeficiency virus (HIV) and related diseases such as acquired immunodeficiency (AIDS) and AIDS-related complex (ARC). Diagnostic methods, vaccination, and therapeutic methods as well as kits employing these compositions are also described.

AR33638296A 1995-05-01 1996-05-02 Compositions and methods for detecting and treating acquired immunodeficiency syndrome AR001840A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43188395A 1995-05-01 1995-05-01
US48554895A 1995-06-07 1995-06-07

Publications (1)

Publication Number Publication Date
AR001840A1 true AR001840A1 (en) 1997-12-10

Family

ID=27029254

Family Applications (1)

Application Number Title Priority Date Filing Date
AR33638296A AR001840A1 (en) 1995-05-01 1996-05-02 Compositions and methods for detecting and treating acquired immunodeficiency syndrome

Country Status (6)

Country Link
JP (1) JP3816524B2 (en)
AR (1) AR001840A1 (en)
AU (1) AU721463B2 (en)
BR (1) BR9608837A (en)
NZ (1) NZ308708A (en)
WO (1) WO1996034886A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8957031B2 (en) 2007-10-23 2015-02-17 Regents Of The University Of Colorado, A Body Corporate Competitive inhibitors of invariant chain expression and/or ectopic clip binding
CA2736842A1 (en) * 2008-07-25 2010-01-28 The Regents Of The University Of Colorado Proteins for use in diagnosing and treating infection and disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415553A (en) * 1973-08-06 1983-11-15 Dso "Pharmachim" Compositions, processes for their preparation and method for treatment of neoplasms
US4818763A (en) * 1984-01-12 1989-04-04 Volker Rusch Biologically active substance with hormonal properties, production process thereof and utilization of histones for medical purposes
AU2800389A (en) * 1987-12-02 1989-07-05 Regents Of The University Of California, The Aids-related anti-t-cell antibody test
GB9209874D0 (en) * 1992-05-07 1992-06-24 Ml Lab Plc Pharmaceutical compositions

Also Published As

Publication number Publication date
JP2002504885A (en) 2002-02-12
AU5851996A (en) 1996-11-21
NZ308708A (en) 1998-11-25
BR9608837A (en) 1999-12-07
JP3816524B2 (en) 2006-08-30
WO1996034886A1 (en) 1996-11-07
AU721463B2 (en) 2000-07-06

Similar Documents

Publication Publication Date Title
Zagury et al. A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS
MX9403380A (en) HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS.
ES2194015T3 (en) NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES OF THE HUMAN IMMUNODEFICIENCY VIRUS.
ATE122237T1 (en) HIV-1 NEUTRALIZING MONOCLONAL ANTIBODIES.
ES2053413T3 (en) PEPTIDES INDUCING ANTIBODIES THAT NEUTRALIZE GENETICALLY DIVERGENT HIV-1 ISOLATES.
CY1106207T1 (en) ANTIINIC NUCLEOSITE DERIVATIVES
DE68927348T2 (en) ARTIFICIAL VACCINE AGAINST AIDS VIRUS
OA08652A (en) Compositions, vaccine and monoclonal antibodies useful for the treatment of conditions caused by the HIV virus and methods for producing these antibodies and for diagnosing the presence of this virus.
ES2078971T3 (en) VIRUS PRODUCTION AND VIRIC ENVELOPE PROTEIN PURIFICATION FOR USE IN VACCINES.
AR001840A1 (en) Compositions and methods for detecting and treating acquired immunodeficiency syndrome
ATE177843T1 (en) PEPTOMERS WITH INCREASED IMMUNOGENICITY
ES2163028T3 (en) COMPOSITIONS AND METHODS TO DETECT AND TREAT THE ACQUIRED IMMUNODEFICIENCY SYNDROME.
ES2166752T3 (en) ASSOCIATION BETWEEN A RETROVIRUS RELATED TO THE HUMAN IMMUNODEFICIENCY VIRUS AND SJOGREN SYNDROME.
ES2062455T3 (en) NEW DERIVATIVES OF BENZONAFTIRIDINA-1,8, ITS PREPARATION AND THE COMPOSITIONS THAT CONTAIN THEM.
ES2196456T3 (en) FIVE LINK CYCLING COMPOUNDS IN THE CONDENSED RING THAT CARRY A SULFONAMIDE GROUP, ITS USE AS PHARMACEUTICAL MEDICINES AND COMPOSITIONS CONTAINING THEM.
ES2057579T3 (en) PEPTIDES E1 AND C OF RUBEOLA.
ES2137378T3 (en) POLYAMAMIFIED PEPTIDIC STRUCTURES TO BE USED AGAINST HIV.
MX9301747A (en) MICROORGANISMS ABLE TO SELECTIVELY PRODUCE COMPOUNDS A AND B FROM STREPTOGRAMS, PROCEDURE FOR THEIR PREPARATION AND THE STREPTOGRAMS PRODUCED FROM THEM.
ES2195200T3 (en) MULTIPLE BRANCH PEPTIDES CONSTRUCTION.
ATE284709T1 (en) VIRAL CHIMERAS FROM CAEV AND HIV-1 GENETIC ELEMENTS
PE87398A1 (en) ANTIVIRAL COMBINATIONS
ES2081782T3 (en) EXTRACTS FROM PILIOSTIGMA THONNINGIL, ITS USE AND FORMULATIONS CONTAINING THEM.
ES2165042T3 (en) VACCINE CONTAINING THE VIRUS OF GOAT ARTHRITIS-ENCEPHALITIS AND USE FOR IMMUNOPROTECTION AGAINST HIV-1 INFECTION.
Leonhards Antigen-Specific Immune Responses Mediated by NK Cells in HIV and Influenza
ES2060162T3 (en) USE OF MONOCLONAL ANTI-B2 MICROGLOBULIN ANTIBODIES.

Legal Events

Date Code Title Description
FB Suspension of granting procedure